Papel de las estatinas en la enfermedad renal crónica (ERC)

  1. Goicoechea Diezhandino, Maria Angeles
  2. García de Vinuesa, Soledad
  3. Lahera Juliá, Vicente
  4. Cachofeiro Ramos, María Victoria
  5. Verdalles Guzmán, Úrsula
  6. Luño Fernández, José
Clínica e investigación en arteriosclerosis

ISSN: 0214-9168 1578-1879

Year of publication: 2010

Volume: 22

Issue: 1

Pages: 17-24

Type: Article

More publications in: Clínica e investigación en arteriosclerosis


SCImago Journal Rank

  • Year 2010
  • SJR Journal Impact: 0.105
  • Best Quartile: Q4
  • Area: Cardiology and Cardiovascular Medicine Quartile: Q4 Rank in area: 288/337
  • Area: Pharmacology (medical) Quartile: Q4 Rank in area: 218/263


Statins have been shown to reduce cardiovascular morbidity and mortality in the general population. In addition to their cholesterol-lowering effect, these drugs have other protective pleiotropic effects on the cardiovascular system. However, the effect of statins on cardiovascular risk in patients with chronic renal disease (CRD) is controversial. Moreover, the question of whether statins delay the progression of CRD and the effect of these drugs on proteinuria remain to be elucidated. The present review discusses the lipid alterations present in CRD and the possible effects of statins on inflammation, CRD progression, proteinuria and cardiovascular risk in this population group.